Firefly luciferase-based chronological measurement of effector CD8+ T-cell activity using a multi-chamber luminometer

被引:1
|
作者
Hayashi, Ryota [1 ]
Nakatani, Hayato [2 ]
Kawahata, Hinami [2 ]
Fujie, Ryonosuke [1 ]
Kurowarabe, Kaoru [1 ]
Hayasaka, Haruko [1 ,2 ,3 ]
机构
[1] 1Kindai Univ, Grad Sch Sci & Engn, Dept Sci, Higashiosaka, Osaka 5778502, Japan
[2] 2Kindai Univ, Fac Sci & Engn, Higashiosaka, Osaka 5778502, Japan
[3] Kindai Univ, Inst Sci & Technol 3Research, Higashiosaka, Osaka 5778502, Japan
关键词
bioluminescence; CD8(+) T cell; luciferase; melanoma; IMMUNITY; IDENTIFICATION; IMMUNOTHERAPY; CYTOTOXICITY; VACCINE; ASSAY;
D O I
10.4155/bio-2022-0208
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Although cell-mediated cytotoxicity has been evaluated with various protocols, methods for monitoring cytotoxicity in a time series have not been established. This work describes a method for evaluating cytotoxicity using a multi-chamber real-time luminometer. Materials & methods: The efficiency of effector CD8(+) T-cell expansion from melanoma-bearing splenocytes was analyzed. The effect of CD8(+) T cells on the viability of luciferase-expressing target cells was measured by bioluminescence. Results: Melanoma-specific effector CD8(+) T cells were differentiated by in vitro coculture. The melanoma cell growth was significantly inhibited in the presence of in vitro-expanded T cells in the bioluminescence-based time-lapse analysis. Conclusion: The bioluminescence-based assay is a useful method for monitoring the time course of cell viability of target tumor cells.
引用
收藏
页码:1413 / 1421
页数:9
相关论文
共 50 条
  • [31] A Synthetic DNA, Multi-Neoantigen Vaccine Drives Predominately MHC Class I CD8+ T-cell Responses, Impacting Tumor Challenge
    Duperret, Elizabeth K.
    Perales-Puchalt, Alfredo
    Stoltz, Regina
    Hiranjith, G. H.
    Mandloi, Nitin
    Barlow, James
    Chaudhuri, Amitabha
    Sardesai, Niranjan Y.
    Weiner, David B.
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02) : 174 - 182
  • [32] Ex Vivo Monitoring of Human Cytomegalovirus-Specific CD8+ T-Cell Responses Using the QuantiFERON®-CMV Assay in Allogeneic Hematopoietic Stem Cell Transplant Recipients Attending an Irish Hospital
    Fleming, T.
    Dunne, J.
    Crowley, B.
    JOURNAL OF MEDICAL VIROLOGY, 2010, 82 (03) : 433 - 440
  • [33] Intratumoral Interleukin-21 Increases Antitumor Immunity, Tumor-infiltrating CD8+ T-cell Density and Activity, and Enlarges Draining Lymph Nodes
    Sondergaard, Henrik
    Galsgaard, Elisabeth D.
    Bartholomaeussen, Monica
    Straten, Per Thor
    Odum, Niels
    Skak, Kresten
    JOURNAL OF IMMUNOTHERAPY, 2010, 33 (03) : 236 - 249
  • [34] Identification of the CD8+ T-cell Related Signature for Predicting the Prognosis of Gastric Cancer Based on Integrated Analysis of Bulk and Single-cell RNA Sequencing Data
    Zhu, Zhi-gang
    Wang, Zheng
    Wu, Qiong
    Miao, Dong-liu
    Jin, Yi-qi
    Chen, Lei
    JOURNAL OF IMMUNOTHERAPY, 2024, 47 (07) : 239 - 248
  • [35] Immunoinformatics prediction of overlapping CD8+ T-cell, IFN-γ and IL-4 inducer CD4+ T-cell and linear B-cell epitopes based vaccines against COVID-19 (SARS-CoV-2)
    Fatoba, Abiodun J.
    Maharaj, Leah
    Adeleke, Victoria T.
    Okpeku, Moses
    Adeniyi, Adebayo A.
    Adeleke, Matthew A.
    VACCINE, 2021, 39 (07) : 1111 - 1121
  • [36] A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized'' HLA Transgenic Rabbit Model
    Srivastava, Ruchi
    Khan, Arif A.
    Huang, Jiawei
    Nesburn, Anthony B.
    Wechsler, Steven L.
    BenMohamed, Lbachir
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (06) : 4013 - 4028
  • [37] IL-15 Trans-Signaling with the Superagonist RLI Promotes Effector/Memory CD8+ T Cell Responses and Enhances Antitumor Activity of PD-1 Antagonists
    Desbois, Melanie
    Le Vu, Pauline
    Coutzac, Clelia
    Marcheteau, Elie
    Beal, Coralie
    Terme, Magali
    Gey, Alain
    Morisseau, Sebastien
    Teppaz, Geraldine
    Boselli, Lisa
    Jacques, Yannick
    Bechard, David
    Tartour, Eric
    Cassard, Lydie
    Chaput, Nathalie
    JOURNAL OF IMMUNOLOGY, 2016, 197 (01) : 168 - 178
  • [38] Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
    Russell Towers
    Lidia Trombello
    Maximilian Fusenig
    Antje Tunger
    Anna-Lena Baumann
    Roberto Savoldelli
    Rebekka Wehner
    Frederick Fasslrinner
    Claudia Arndt
    Francesco Dazzi
    Malte Von Bonin
    Anja Feldmann
    Michael P. Bachmann
    Manja Wobus
    Marc Schmitz
    Martin Bornhäuser
    Cancer Immunology, Immunotherapy, 2024, 73
  • [39] Bone marrow-derived mesenchymal stromal cells obstruct AML-targeting CD8+ clonal effector and CAR T-cell function while promoting a senescence-associated phenotype
    Towers, Russell
    Trombello, Lidia
    Fusenig, Maximilian
    Tunger, Antje
    Baumann, Anna-Lena
    Savoldelli, Roberto
    Wehner, Rebekka
    Fasslrinner, Frederick
    Arndt, Claudia
    Dazzi, Francesco
    Von Bonin, Malte
    Feldmann, Anja
    Bachmann, Michael P.
    Wobus, Manja
    Schmitz, Marc
    Bornhaeuser, Martin
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2024, 73 (01)
  • [40] Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8+ T-cell antitumor activity via the non-canonical P53/STING pathway
    Wu, Jie
    Liu, Nian
    Chen, Jing
    Tao, Qian
    Lu, Can
    Li, Qiuqiu
    Chen, Xiang
    Peng, Cong
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2025, 13 (02)